China has been touting the success of its COVID-19 vaccines at home and abroad, luring a number of countries into purchasing Sinovac and Sinopharm, two front-runner Chinese vaccines. Moreover, whenever a foreign sale is made, Chinese authorities immediately cite it as proof of popularity and effectiveness in the propaganda it uses inside China. Such propaganda has indeed achieved a certain amount of success both inside the country and in the international community. However, recent deaths and the low protection rate of Chinese-made vaccines revealed by clinical trials and real-life cases, should put an end to that self-proclaimed “success.” Deaths and Serious Adverse Reactions in Hong Kong and Mainland To date, Hong Kong authorities have reported 14 deaths in Hong Kong that occurred after vaccination with Sinovac, while another 13 people have developed facial paralysis after receiving the vaccine, since vaccinations began 50 days ago. In mainland China, where approximately 160 …